Hf. Hart et al., EFFECT OF TERMINAL (DRY) HEAT-TREATMENT ON NONENVELOPED VIRUSES IN COAGULATION-FACTOR CONCENTRATES, Vox sanguinis, 67(4), 1994, pp. 345-350
Terminal dry heat treatment effectively inactivated hepatitis A virus
(HAV) and canine parvovirus added to high-purity factor VIII. After 24
h at 80 degrees C, HAV infectivity was reduced by greater than or equ
al to 4.3 log(10) TCID50, as measured in a newly developed infectivity
assay. The same reduction in virus titer was achieved after 2 h and b
efore 6 h at 90 degrees C. Inactivation of hepatitis A virus was also
seen in the freeze-drying step prior to heat treatment with an approxi
mately 2.0 log(10) reduction in titer. Similar results were obtained w
ith a high-purity factor IX concentrate. Canine parvovirus was also in
activated at both temperatures, with residual infectivity being undete
cted after 48 h at 80 degrees C or 10 h at 90 degrees C. Canine parvov
irus was not affected by lyophilisation. Canine parvovirus measurement
s by PCR did not reflect the levels of infectivity measured by the tis
sue-culture-based method. The addition of the terminal dry heat treatm
ent to solvent/detergent could effectively eliminate the potential con
tamination of solvent/detergent-treated coagulation factor concentrate
s by non-lipid-enveloped viruses. However, careful evaluation for any
increased induction of non-antigens for factor VIII, as a consequence
of such treatment, is needed before use in patients can be recommended
.